Quest Diagnostics Pre-Paid Expenses 2010-2024 | DGX

Quest Diagnostics pre-paid expenses from 2010 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
  • Quest Diagnostics pre-paid expenses for the quarter ending September 30, 2024 were $0.299B, a 44.44% increase year-over-year.
  • Quest Diagnostics pre-paid expenses for 2023 were $0.286B, a 45.92% increase from 2022.
  • Quest Diagnostics pre-paid expenses for 2022 were $0.196B, a 12.11% decline from 2021.
  • Quest Diagnostics pre-paid expenses for 2021 were $0.223B, a 42.04% increase from 2020.
Quest Diagnostics Annual Pre-Paid Expenses
(Millions of US $)
2023 $286
2022 $196
2021 $223
2020 $157
2019 $112
2018 $144
2017 $150
2016 $155
2015 $207
2014 $186
2013 $105
2012 $91
2011 $87
2010 $92
2009 $95
Quest Diagnostics Quarterly Pre-Paid Expenses
(Millions of US $)
2024-09-30 $299
2024-06-30 $245
2024-03-31 $251
2023-12-31 $286
2023-09-30 $207
2023-06-30 $188
2023-03-31 $195
2022-12-31 $196
2022-09-30 $171
2022-06-30 $156
2022-03-31 $195
2021-12-31 $223
2021-09-30 $189
2021-06-30 $132
2021-03-31 $164
2020-12-31 $157
2020-09-30 $117
2020-06-30 $112
2020-03-31 $120
2019-12-31 $112
2019-09-30 $116
2019-06-30 $100
2019-03-31 $137
2018-12-31 $144
2018-09-30 $148
2018-06-30 $137
2018-03-31 $127
2017-12-31 $150
2017-09-30 $134
2017-06-30 $156
2017-03-31 $154
2016-12-31 $155
2016-09-30 $179
2016-06-30 $163
2016-03-31 $138
2015-12-31 $207
2015-09-30 $194
2015-06-30 $173
2015-03-31 $188
2014-12-31 $186
2014-09-30 $164
2014-06-30 $125
2014-03-31 $115
2013-12-31 $105
2013-09-30 $109
2013-06-30 $126
2013-03-31 $98
2012-12-31 $91
2012-09-30 $86
2012-06-30 $108
2012-03-31 $139
2011-12-31 $87
2011-09-30 $97
2011-06-30 $110
2011-03-31 $111
2010-12-31 $92
2010-09-30 $95
2010-06-30 $102
2010-03-31 $106
2009-12-31 $95
2009-09-30 $100
2009-06-30 $90
2009-03-31 $99
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $16.912B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
Amedisys (AMED) United States $2.744B 19.53
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00